Madrigal Pharmaceuticals, Inc.
MDGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001157601
In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Madrigal Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 137 | 151 | +14 |
| Shares | 12.2M | 11.2M | −981.2K (−8.0%) |
| Value | $1.43B | $1.09B | −$334.0M (−23.4%) |
New holders (31)
Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (17)
Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| PFM Health Sciences, LP | 82,534 | $9.65M |
| Candriam Luxembourg S.C.A. | 31,722 | $3.39M |
| Natixis | 22,000 | $2.57M |
| California Public Employees Retirement System | 17,900 | $2.09M |
| Assenagon Asset Management S.A. | 16,098 | $1.88M |
| Aviva PLC | 10,495 | $1.23M |
| Mackay Shields LLC | 6,261 | $733.0K |
| Los Angeles Capital Management LLC | 6,260 | $732.0K |
| Susquehanna Fundamental Investments, LLC | 2,068 | $242.0K |
| Pacer Advisors, Inc. | 656 | $77.0K |
| ShoreHaven Wealth Partners, LLC | 534 | $62.0K |
| Bank of Montreal | 261 | $31.0K |
| Sowell Financial Services LLC | 180 | $23.0K |
| Wolverine Asset Management LLC | 126 | $14.0K |
| Eaton Vance Management | 45 | $5.00K |
| TCI Wealth Advisors, Inc. | 16 | $2.00K |
| Lindbrook Capital, LLC | 4 | $0 |